123 related articles for article (PubMed ID: 4527840)
1. Immunotherapy for acute myelogenous leukaemia.
Powles R
Ir J Med Sci; 1974 Jul; 0(0):suppl:10-3. PubMed ID: 4527840
[No Abstract] [Full Text] [Related]
2. Active specific immunotherapy for acute myelogenous leukaemia.
Powles R
Johns Hopkins Med J Suppl; 1974; 3():333-40. PubMed ID: 4609353
[No Abstract] [Full Text] [Related]
3. Editorial: Immunotherapy for acute myeloid leukaemia.
Lancet; 1974 May; 1(7862):846-7. PubMed ID: 4132795
[No Abstract] [Full Text] [Related]
4. HL-A antibody response in patients with acute myelogenous leukaemia treated by immunotherapy.
Klouda TP; Lawler SD; Powles RL; Oliver RT; Grant CK
Transplantation; 1975 Mar; 19(3):245-9. PubMed ID: 1094639
[No Abstract] [Full Text] [Related]
5. Immunotherapy of acute myelogenous leukemia in man.
Powles R
Natl Cancer Inst Monogr; 1973 Dec; 39():243-7. PubMed ID: 4595324
[No Abstract] [Full Text] [Related]
6. Inability to demonstrate lytic antibodies to autologous leukaemia cells in the sera from remission patients with acute myelogenous leukaemia treated with active specific immunotherapy.
Chapuis BJ; Powles R; Alexander P
Clin Exp Immunol; 1978 May; 32(2):253-8. PubMed ID: 276431
[TBL] [Abstract][Full Text] [Related]
7. [Immunotherapy for acute myelogenous leukemia with Nocardia rubra cell-wall skeleton. A randomized controlled study].
Nakamura H; Masaoka T; Ohno R; Yamada K; Ogawa N
Nihon Ketsueki Gakkai Zasshi; 1983 Sep; 46(5):1087-92. PubMed ID: 6582752
[No Abstract] [Full Text] [Related]
8. Immunotherapy for acute myelogenous leukaemia.
Harris R; Zuhrie SR
Lancet; 1977 Dec; 2(8050):1228. PubMed ID: 73925
[No Abstract] [Full Text] [Related]
9. Immunological studies in patients receiving Corynebacterium parvum (C.P.) as immunotherapy for acute myelogenous leukemia (AML).
Pai VR; Shetty PA; Jussawalla DJ
Indian J Cancer; 1982; 19(3):149-52. PubMed ID: 6959958
[No Abstract] [Full Text] [Related]
10. Immunotherapy for acute myelogenous leukaemia.
Powles RL; Crowther D; Bateman CJ; Beard ME; McElwain TJ; Russell J; Lister TA; Whitehouse JM; Wrigley PF; Pike M; Alexander P; Fairley GH
Br J Cancer; 1973 Nov; 28(5):365-76. PubMed ID: 4271320
[TBL] [Abstract][Full Text] [Related]
11. [General strategy for acute myelogenous leukaemia therapy (author's transl)].
Fernández-Rañada J; Escudero A; Vázquez L; Gómez-Reino F; Fernández-Villalta MJ; Fernández de Pivel D; Merino JL; Olmeda F
Sangre (Barc); 1981; 26(5B):855-66. PubMed ID: 7034245
[No Abstract] [Full Text] [Related]
12. Immunotherapy in the treatment of acute leukaemia.
Whittaker JA
Br J Haematol; 1980 Jun; 45(2):187-93. PubMed ID: 6934004
[No Abstract] [Full Text] [Related]
13. Immunotherapy for acute myelogenous leukaemia.
Powles R
Br J Cancer Suppl; 1973 Aug; 1():262-5. PubMed ID: 4531352
[No Abstract] [Full Text] [Related]
14. Developmental approaches in immunological control of acute myelogenous leukaemia.
Torelli GF; Orsini E; Guarini A; Kell J; Foà R
Best Pract Res Clin Haematol; 2001 Mar; 14(1):189-209. PubMed ID: 11355931
[TBL] [Abstract][Full Text] [Related]
15. Proceedings: Cell mediated cytotoxicity (CMC) in patients with acute myeloblastic leukaemia receiving immunotherapy.
Taylor GM; Harris R; Freeman CB
Br J Cancer; 1975 Aug; 32(2):242. PubMed ID: 1061614
[No Abstract] [Full Text] [Related]
16. Immunotherapy alone vs no maintenance treatment in acute myelogenous leukaemia.
Zuhrie SR; Harris R; Freeman CB; MacIver JE; Geary CG; Delamore IW; Tooth JA
Br J Cancer; 1980 Mar; 41(3):372-7. PubMed ID: 6992827
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapy for acute myelogenous leukemia using irradiated and unirradiated leukemia cells.
Powles R
Cancer; 1974 Oct; 34(4 Suppl):suppl:1558-62. PubMed ID: 4608692
[No Abstract] [Full Text] [Related]
18. The effect of immunotherapy on survival of patients with acute myelogenous leukaemia after relapse.
Powles R; Toy JL
Haematologia (Budap); 1976; 10(1):5-9. PubMed ID: 1070466
[TBL] [Abstract][Full Text] [Related]
19. Chemoimmunotherapy of adult acute leukaemia. Prolongation of remission in myeloblastic leukaemia with B.C.G.
Gutterman JU; Hersh EM; Rodriguez V; McCredie KB; Mavligit G; Reed R; Burgess MA; Smith T; Gehan E; Bodey GP; Freireich EJ
Lancet; 1974 Dec; 2(7894):1405-9. PubMed ID: 4140327
[No Abstract] [Full Text] [Related]
20. Immunotherapy for acute myelogenous leukaemia: a controlled clinical study 2 1/2 years after entry of the last patient.
Powles RL; Russell J; Lister TA; Oliver T; Whitehouse JM; Malpas J; Chapuis B; Crowther D; Alexander P
Br J Cancer; 1977 Mar; 35(3):265-72. PubMed ID: 322689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
